Premise: In the preamble to the rule, FDA presents a summary of its economic analyses, discussing the potential benefits of the proposed rule and the economic impact that could occur as a result of its implementation.

Hypothesis: There is no preamble to the rule, the FDA neglected to draft one.
Relation: contradiction